We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$658M
AUM Growth
+$41.6M
Cap. Flow
-$2.26M
Cap. Flow %
-0.34%
Top 10 Hldgs %
27.12%
Holding
136
New
3
Increased
48
Reduced
56
Closed
10

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$2.62M
2
YUM icon
Yum! Brands
YUM
+$1.59M
3
FDX icon
FedEx
FDX
+$1.53M
4
BMY icon
Bristol-Myers Squibb
BMY
+$1.47M
5
GLW icon
Corning
GLW
+$1.12M

Sector Composition

Rank Sector Weight
1 Technology 21.41%
2 Healthcare 18.95%
3 Industrials 13.46%
4 Communication Services 10.9%
5 Consumer Staples 10.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOW icon
126
Lowe's Companies
LOW
$117B
-2,135
Closed -$234K
TXN icon
127
Texas Instruments
TXN
$252B
-2,656
Closed -$343K
PXD
128
DELISTED
Pioneer Natural Resource Co.
PXD
-8,083
Closed -$1.02M
TWTR
129
DELISTED
Twitter, Inc.
TWTR
-9,090
Closed -$374K
GWR
130
DELISTED
Genesee & Wyoming Inc.
GWR
-6,095
Closed -$673K
CELG
131
DELISTED
Celgene Corp
CELG
-21,939
Closed -$2.18M

Similar funds

Jacobs & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Jacobs & Co held 136 positions worth $658M, up 6.8% from $617M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jacobs & Co's Q4 2019 filing shows 3 new, 48 increased, 56 reduced and 10 closed positions. Its largest new stake was Biogen: 9,440 shares worth $2.8M. The largest sale was Celgene Corp, an estimated $2.18M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

  • Jacobs & Co's largest Q4 2019 buy was Biogen: 9,440 shares worth $2.8M.
  • Jacobs & Co added most to Yum! Brands in Q4 2019, an estimated $1.59M increase.
  • Jacobs & Co's biggest Q4 2019 reduction was Chevron, cutting an estimated $1.86M.
  • Jacobs & Co fully exited Celgene Corp in Q4 2019, selling an estimated $2.18M.
  • Jacobs & Co's ten largest holdings make up 27% of its $658M portfolio in Q4 2019.
  • Jacobs & Co opened 3 new positions and closed 10 in Q4 2019.
  • Jacobs & Co's portfolio value rose 6.8% quarter-over-quarter to $658M.

Based on Jacobs & Co's 13F filing for Q4 2019, filed 29 Jan 2020.